Kit Pharmacacological Terms

Front 1

ANY CHEMICAL SUBSTANCE THAT HAS AN EFFECT ON LIVING TISSUE BUT IS NOT USED AS A FOOD

Back 1

DRUG

Hint 1

ZERO TOLERANCE

Front 2

RELIEVES SYMPTOMS OF DISEASE

Back 2

THERAPEUTIC

Front 3

PREVENT OR DECREASE SEVERITY OF DIESEASE

Back 3

PROPHYLACTIC

Hint 3

A TOOL TO PREVENT STDS

Front 4

THE SCIENCE OF DOSAGES

Back 4

POSOLOGY

Front 5

THE BRANCH OF PHARMACOLOGY THAT DEALS WITH THE SCIENTIFIC STUDY OF ABSORPTION, DISTRIBUTION AND EXCRETION (ADME)

Back 5

PHARMACOKINETICS

Front 6

THE PROCESS BY WHICH A SUBSTANCE IS TAKEN UP FROM THE SITE OF ADMINISTRATION THE SYSTEM

Back 6

ABSORPTION

Hint 6

A=A
ADMINSTRATION=

Front 7

THE PROCESS OF MOVEMENT OF THE DRUG THROUGH THE BLOOD AND TRANSFER FROM THE BLOOD TO OTHER BODILY FLUIDS AND TISSUES

Back 7

DISTRUBUTION

Hint 7

NOT A STREET PHARMACISIT, BUT A DRUG ....

Front 8

THE TRANSFORMATION OF THE DRUG BY PHYSIOLOGICAL PROCESSES OF THE BODY INTO OTHER FORMS, USUALLY LESS POTENT OR TOXIC THAN THE ORIGINAL FORM THAT CAN BE ELIMINATED

Back 8

METABOLISM

Hint 8

YOU WANT TO TRANSFORM YOUR BODY, YOU WANT TO RAISE YOUR...

Front 9

THE STUDY OF DRUG ACTION ON LIVING ORGANISMS

Back 9

PHARMACODYNAMICS

Hint 9

ACTION

Front 10

THE STUDY OF OF THE ECONOMIC ASPECTS OF DRUGS

Back 10

PHARMACOECONOMICS

Hint 10

ECONOMY

Front 11

ANY CONDITION ACCOMPANYING OR RESULTING FROM A DISEASE, DISORDER OR OTHERABNORMALITY THAT PROVIDES EVIDENCE FOR ITS EXISTENCE

Back 11

SYMPTOMS

Hint 11

GENERALLY REFERRED TO AS THE PATIENT'S DESCRIPTION OF THE PHYSICAL SENSATION EXPERIENCED

Front 12

A SET OF S/SX THAT OCCUR TOGETHER AND CHARACTERIZE A PARTICULAR DISEASE OR DISORDER

Back 12

SYNDROME

Hint 12

DISEASE=DISORDER=DOWNS

Front 13

LOCATION IN THE BODY WHERE THE DRUG EXERTS ITS EFFECT. INCLUDES LOCAL USE OR SYSTEMIC USE

Back 13

SITE OF ACTION

Front 14

REFERS TO THE SITE SPECIFIC APPLICATION OF DRUGS, SUCH AS AN ANALGESIC OINTMENT APPLIED TO A BURN

Back 14

LOCAL

Hint 14

YOU APPLY AN OINTMENT, IT NUMBS CREATING A ... ANALGESIC

Front 15

REFERS TO APPLICATION OF A DRUGBY MEANS OF ABSORPTION INTO THE BLOOD AND SUBSEQUENT TRANSPORTATION THROUGHOUT THE BODY

Back 15

SYSTEMIC

Hint 15

ABSORBS INTO BLOOD

Front 16

HOW THE DRUG PRODUCES ITS EFFECTS IN THE BODY. INCLUDES AGONIST/ANTAGONIST EFFECT/NONSPECIFIC MEMBRANE LIPID INTERACTION/PROTEIN BINDING/OSMOTIC EFFECT

Back 16

MECHANISM OF ACTION

Front 17

LOCATION ON THE SURFACE OR WITHIN THE CELL THAT CONTAIN SPECIFIC PROTEIN MOLECULES THAT BIND TO OTHER SPECIFIC MOLECULES, PRODUCING SOME EFFECT IN THE CELL.

Back 17

RECEPTOR SITE

Hint 17

LOCATION

Front 18

A DRUG THAT BINDS TO PARTICULAR RECEPTOR SITE AND TRIGGERS THE CELLS RESPONSE IN A SIMILAR WAY TO THE BODY'S OWN CHEMICAL MESSENGER

Back 18

AGONIST

Hint 18

RESPONSE IN A SIMILAR WAY

Front 19

A DRUG THAT BINDS TO A PARTICULAR RECEPTOR SITE AND BLOCKS THE ACTION OF THE ENDOGENOUS CHEMICAL MESSENGER WITHOUT TRIGGERING THE CELL'S RESPONSE.

Back 19

ANTAGONIST

Hint 19

BLOCKS THE ACTION

Front 20

THE MAXIMUM THERAPEUTIC DOSE, ABOVE WHICH NO IMPROVED CLINICAL RESPONSE WILL OCCUR

Back 20

CEILING EFFECT

Front 21

THE LENGTH OF TIME A DRUG IS AT THERAPEUTIC CONCENTRATION LEVEL

Back 21

DURATION OF ACTION (DOA)

Front 22

THE TIME PERIOD REQUIRED AFTER ADMINISTRATION OF A DRUG TO ACHIEVE THE DESIRED RESPONSE, OR THERAPEUTIC CONCENTRATION LEVEL.

Back 22

ONSET OF ACTION

Hint 22

TIME PERIOD

Front 23

THE DRUG DOSE THAT WILL PRODUCE A THERAPEUTIC RESPONSE IN 50 PERCENT OF THE POPULATION WHO RECEIVED THE DRUG

Back 23

EFFECTIVE DOSE 50

Front 24

THE DOSAGE THAT WILL KILL 50% OF THE POPULATION

Back 24

LETHAL DOSE 50

Front 25

UNUSUAL OR UNEXPECTED RESPONSE TO A DRUG. PECULIAR TO THE INDIVIDUAL AND SOMETIMES HAVE GENETIC CAUSES

Back 25

IDIOSYNCRASY

Front 26

A LOCAL OR GENERAL IMMUNE RESPONSE IN WHICH THE IMMUNE SYSTEM OVERREACTS TO AN OTHERWISE HARMLESS SUBSTANCE

Back 26

ALLERGY

Front 27

RESULTING IN IMMEDIATE LIFE THREATENING RESP DISTRESS, USUALLY FOLLOWED BY VASCULAR COLLAPSE AND SHOCK AND ACCOMPANIED BY HIVES

Back 27

SEVERE ALLERGIC REACTION

Front 28

LONGEST DIFFICULT NAME OF THE CHEMICAL MAKE UP THE DRUG AND RELATES TO THE CHEMICAL AND MOLECULAR STRUCTURE

Back 28

CHEMICAL NAME

Front 29

A SHORTENED VERSION OF THE CHEMICAL NAME THAT THE MANUFACTURER GIVES THE DRUG

Back 29

GENERIC NAME

Hint 29

BEGINS WITH LOWERCASE LETTER AND CAN BE USED BY OTHER MANUFACTURERS

Front 30

THE NAME UNDER WHICH THE MANUFACTURER HAS PATENTED THE DRUG

Back 30

TRADE/BRAND NAME

Front 31

THE BRANCH OF PHARMACOLOGY THAT DEALS WITH BIOLOGICAL, BIOCHEMICAL, AND ECONOMIC FEATURES OF NATURAL DRUGS AND THEIR CONSTITUENTS

Back 31

PHARMACOGNOSY

Front 32

PROVIDES STANDARDS FOR DRUGS OF THERAPEUTIC USEFULNESS AND PHARMACEUTICAL NECESSITY.

Back 32

US PHARMACOPEIA AND NATIONAL FORMULARY

Front 33

THE MOST WIDELY USED TEXT/REFERENCE IN AMERICAN PHARMACIES

Back 33

REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY

Front 34

THE THERAPEUTIC DOES IS CALCULATED ON AN AVERAGE ADULT

Back 34

24 YEARS WHO WEIGHS 150 POUNDS

Front 35

DRUGS GROUPED ACCORDING TO THEIR SOURCE, WHETHER ANIMAL, VEGETABLE, OR MINERAL IN ORIGIN

Back 35

GENERAL

Front 36

DRUGS GROUPED BY THEIR CHEMICAL CHARACTERISTICS

Back 36

CHEMICAL

Front 37

DRUGS ARE GROUPED ACCORDING TO THEIR ACTION ON THE BODY

Back 37

THERAPEUTIC

Front 38

HISTAMINE H2 RECEPTOR ANTAGONISTS

Back 38

BLOCKS HISTAMINES THAT CAUSE AN INCREASE OF OF GASTRIC ACID SECRETION IN THE STOMACH. RELIEVES SYMPTOMS OF PEPTIC ULCERS

Front 39

EFFECTIVE AGAINST BOTH GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS. WERE THE FIRST EFFECTIVE CHEMOTHERAPEUTIC AGENTS AVAILABLE

Back 39

SULFONAMIDES

Front 40

MOST EFFECTIVE AND LEAST TOXIC OF THE ANTIMICROBIAL AGENTS

Back 40

PCN